This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: University of California. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Meng-Yin Lin
Introduction
Meng-Yin Lin is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods for cancer treatment.
Latest Patents
Meng-Yin Lin holds a patent for "Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments." This patent discloses compositions that include an isolated chimeric interleukin 6 receptor alpha (IL-6Rα) binding protein or cells expressing this protein. The isolated IL-6Rα chimeric binding protein and the cells that express it may be utilized in methods aimed at treating cancer and reducing the risk of cytokine release syndrome. He has 1 patent to his name.
Career Highlights
Meng-Yin Lin is affiliated with the University of California, where he continues to advance his research and innovations in the field of biotechnology. His work has the potential to impact cancer therapies significantly.
Collaborations
Meng-Yin Lin collaborates with Yvonne Yu-Hsuan Chen, contributing to the advancement of their shared research interests.
Conclusion
Meng-Yin Lin's innovative work in biotechnology, particularly through his patent on interleukin-6 receptor alpha-binding proteins, showcases his commitment to improving cancer treatment methodologies. His contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile